Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment

Artann Laboratories113 enrolled

Overview

Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS parameters will be able to discriminate between postmenopausal women with osteoporotic fractures when compared to matched controls without history of osteoporotic fracture.

One of several studies to develop and clinically validate a novel ultrasonographic device, BUSS, for the assessment of osteoporosis and fracture risk.

Study Type

OBSERVATIONAL

Enrollment

113

Conditions

Osteoporosis Fracture Aging

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * postmenopausal women with osteoporotic fracture at spine or wrist * postmenopausal women no history of fracture at spine or wrist Exclusion Criteria: * women with a history of metabolic disease * stroke * tibia fracture or surgery * BMI ≥ 35 kg/m2 * Teriparatide use currently or within the past 6 months, * Any skin issues (open wounds or rashes, and/or skin infections) of the tibial area.

Locations (1)

Mayo Clinic Rochester

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

Determine whether BUSS testing is equivalent or superior to DXA for fracture risk assessment in postmenopausal women.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.